Market research
6IO.F Inogen, Inc
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 167M
- P/E ratio
- Not available
- Analyst target
- 71
- Dividend yield
- Not available
- Beta
- 1.5
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 167M
- P/E ratio
- Not available
- Analyst target
- 71
- Dividend yield
- Not available
- Beta
- 1.5
About
About Inogen, Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Research context
Inogen, Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 6IO.F discussion.
5 years, 7 months ago
Inogen, Inc is currently in a long term uptrend where the price is trading 37.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Inogen, Inc's total revenue sank by 6.3% to $74M since the same quarter in the previous year.
Its net income has dropped by 272.4% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 41.5% to $10M since the same quarter in the previous year.
Based on the above factors, Inogen, Inc gets an overall score of 3/5.